PubMed ID:
25013994
Public Release Type:
Journal
Publication Year: 2014
Affiliation: Department of Urology (S.K.H., N.L., H.W.), University of Washington, Seattle, Washington 98195; Department of Surgery/Urology (J.H.), University of Utah, Salt Lake City, Utah 84112; Departments of Urology (A.V.S., R.L.D.), Internal Medicine (C.M., W.H.H.), and Epidemiology (W.H.H.), University of Michigan, Ann Arbor, Michigan 48109; Biostatistics Center (P.A.C., B.H.B.), George Washington University, Washington DC 20052; and Department of Medicine (P.G.), Yale University, New Haven, Connecticut 06520.
DOI:
https://doi.org/10.1210/jc.2014-1317
Authors:
Herman WH,
Braffett BH,
Cleary PA,
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group,
Dunn RL,
Gatcomb P,
Holt SK,
Hotaling J,
Lopushnyan N,
Martin C,
Sarma AV,
Wessells H
Studies:
Diabetes Control and Complications Trial
Previous studies have demonstrated lower testosterone concentrations in men with type 2 diabetes mellitus. Data in men with type 1 diabetes mellitus (T1DM) are limited.